Overall, these data demonstrate that MSCs ameliorate lupus symptoms in MRL.Faslpr mice by inhibiting the expression of inflammatory cytokines and chemokines in the kidney, with the exception of CCL8. Here, CCL8 is linked to systemic lupus erythematosus.